Showing 701 - 720 results of 112,366 for search '(( 12 we decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.51s Refine Results
  1. 701

    Loss of ALS2 results in decreased levels of the lysosome-dependent degradation of LC3 in fibroblasts. by Shinji Hadano (251529)

    Published 2010
    “…It is notable that a 6 hr of starvation leads to decreased levels of the LC3- and p62-immunoreactive signals in WT cells, but not in <i>Als2</i><sup>−/−</sup> cells. …”
  2. 702
  3. 703
  4. 704
  5. 705
  6. 706

    AT1 receptor antagonism led to decreased expression of pro-fibrotic and pro-inflammatory factors in the kidney. by Anne-Cécile Huby (5653777)

    Published 2013
    “…Values are mean±SEM; n = 5, 9 and 13 for wild type and RenTg mice before and after irbesartan, respectively; * P<0,05 or ** P<0,01 vs WT; <sup>##</sup> P<0,01 vs RenTg.…”
  7. 707
  8. 708
  9. 709
  10. 710
  11. 711
  12. 712

    Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

    Published 2016
    “…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”
  13. 713
  14. 714
  15. 715
  16. 716

    Data_Sheet_1_Effect of decreased platelets on postoperative recurrence of chronic subdural hematoma.docx by Kenji Yagi (2990967)

    Published 2023
    “…CSDH recurred in 39 (8.5%) cerebral hemispheres. The recurrence rate was gradually increased in parallel with a decreasing PC. …”
  17. 717
  18. 718
  19. 719
  20. 720

    Decreased Variability of the 6-Minute Walk Test by Heart Rate Correction in Patients with Neuromuscular Disease by Kira P. Prahm (670305)

    Published 2014
    “…</p><p>Conclusion</p><p>A modified 6-minute walk test, by correcting walking distance with average heart rate during walking, decreases the variability among repeated 6-minute walk tests, and should be considered as an alternative outcome measure to the standard 6-minute walk test in future clinical follow-up and treatment trials.…”